The University of Chicago Header Logo

Connection

Theodore Karrison to Dasatinib

Back to Details
This is a "connection" page, showing publications Theodore Karrison has written about Dasatinib.
Theodore Karrison
Connection Strength
0.128
Dasatinib
  1. Phase II trial of dasatinib for recurrent or metastatic c-KIT expressing adenoid cystic carcinoma and for nonadenoid cystic malignant salivary tumors. Ann Oncol. 2016 Feb; 27(2):318-23.
    View in: PubMed
    Score: 0.128
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.